Medical Properties Trust Inc. (MPW) had a rough trading day for Tuesday November 05 as shares tumbled 6.16%, or a loss of $-1.26 per share, to close at $19.18. After opening the day at $19.82, shares of Medical Properties Trust Inc. traded as high as $19.88 and as low as $19.15. Volume was 13.16 million shares over 64,078 trades, against an average daily volume of n/a shares and a total float of 446.29 million.
As a result of the decline, Medical Properties Trust Inc. now has a market cap of $8.56 billion. In the last year, shares of Medical Properties Trust Inc. have traded between a range of $20.92 and $15.25, and its 50-day SMA is currently $n/a and 200-day SMA is $n/a.
Medical Properties Trust Inc is a healthcare facility REIT. The company operates one segment, which owns and leases healthcare facilities. The vast majority of Medical’s revenue is generated in the United States, followed by Germany and the United Kingdom. The company considers merger and acquisition investment as a component of its operational growth strategy. It provides financing for a variety of facilities that require funds for acquisitions, sale-leasebacks, new developments, and expansion projects.
Medical Properties Trust Inc. is based out of Birmingham, AL and has some 77 employees. Its CEO is Edward K. Aldag.
Medical Properties Trust Inc. is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives a broad, unbiased look at the small-cap market as a whole.